Insulcloud won an SME instrument grant to develop the Insulclock medical device, a small electronic device very easily plugged into any insulin-injection pen, which helps patients automatically track critical information about their treatment, such as remembering the date, time and dosage of the last shot and the time of the next one, as well as monitoring the type of insulin and its temperature. A reminder system which employs visual and acoustic alerts avoids mistakes and omissions.
Qi provided coaching services, assigned by the European Commission (EASME), to the company aiming to accelerate the penetration of the emerging company in the marketplace.
The company had significant challenges ahead in terms of product refining, clinical trials, product certification, app development (telemedicine), production organisation, internal restructuring, marketing and sales launching at national and international levels (market segmentation), cooperation agreements and phase III access. In all these phases, our coach service was required to optimise those activities, reducing dead time and accelerating the market uptake.